Magnetic resonance coronary angiography with vasovist™: In-vivo T1 estimation to improve image quality of navigator and breath-hold techniques

European Radiology

Volumn 18, Issue 1, 2008, Pages 103-109

  Nassenstein, Kai ^a   Waltering, Kai Uwe ^a   Kelle, Sebastian ^b   Schlosser, Thomas ^a   Breuckmann, Frank ^a   Maderwald, Stefan ^a   Hunold, Peter ^a   Nagel, Eike ^b   Barkhausen, Jørg ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Blood pool contrast agent; Magnetic resonance coronary angiography; Vasovist

Indexed keywords

GADOFOSVESET;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CONTROLLED STUDY; DEVICE; DIAGNOSTIC PROCEDURE; DRUG HALF LIFE; DRUG STRUCTURE; FEMALE; HEART MUSCLE; HUMAN; HUMAN EXPERIMENT; IMAGE QUALITY; IN VIVO STUDY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VOLUNTEER;

ADULT; CONTRAST MEDIA; CORONARY DISEASE; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; ORGANOMETALLIC COMPOUNDS; RESPIRATION;

EID: 38949213662     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-007-0720-0     Document Type: Article

References (34)

1. Dissmann W, de Ridder M (2002) The soft science of German cardiology. Lancet 359:2027-2029
2. Karnegis JN, Heinz J (1979) The risk of diagnostic cardiovascular catheterization. Am Heart J 97:291-297
3. Nieman K, Cademartiri F, Lemos PA, Raaijmakers R, Pattynama PM, de Feyter PJ (2002) Reliable noninvasive coronary angiography with fast submillimeter multislice spiral computed tomography. Circulation 106:2051-2054
4. Leber AW, Knez A, Becker C et al (2003) Non-invasive intravenous coronary angiography using electron beam tomography and multislice computed tomography. Heart 89:633-639
5. Barkhausen J, Hunold P, Jochims M et al (2002) Comparison of gradient-echo and steady state free precession sequences for 3D-navigator MR angiography of coronary arteries. Rofo 174:725-730
6. Barkhausen J, Hunold P, Waltering KU (2004) MRI in coronary artery disease. Eur Radiol 14:2155-2162
7. Hackenbroch M, Nehrke K, Gieseke J et al (2005) 3D motion adapted gating (3D MAG): A new navigator technique for accelerated acquisition of free breathing navigator gated 3D coronary MR-angiography. Eur Radiol 15:1598-1606
8. Thomas D, Krug B, Hackmann D et al (2004) MR-coronary angiography: comparison of SSFP and spoiled GRE sequence (bright blood technique) and a TSE sequence (black blood technique) in healthy volunteers. Rofo 176:1589-1598
9. Giorgi B, Dymarkowski S, Maes F, Kouwenhoven M, Bogaert J (2002) Improved visualization of coronary arteries using a new three-dimensional submillimeter MR coronary angiography sequence with balanced gradients. AJR Am J Roentgenol 179:901-910
10. Spuentrup E, Botnar RM (2006) Coronary magnetic resonance imaging: visualization of the vessel lumen and the vessel wall and molecular imaging of arteriothrombosis. Eur Radiol 16:1-14
11. Goldfarb JW, Edelman RR (1998) Coronary arteries: Breath-hold, gadolinium-enhanced, three-dimensional MR angiography. Radiology 206:830-834
12. Zheng J, Li D, Bae KT, Woodard P, Haacke EM (1999) Three-dimensional gadolinium-enhanced coronary magnetic resonance angiography: Initial experience. J Cardiovasc Magn Reson 1:33-41
13. Taupitz M, Schnorr J, Wagner S et al (2002) Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium. Radiology 222:120-126
14. Li D, Zheng J, Weinmann HJ (2001) Contrast-enhanced MR imaging of coronary arteries: Comparison of intra-and extravascular contrast agents in swine. Radiology 218:670-678
15. Herborn CU, Barkhausen J, Paetsch I et al (2003) Coronary arteries: contrast-enhanced MR imaging with SH L 643A-experience in 12 volunteers. Radiology 229:217-223
16. Stuber M, Botnar RM, Danias PG et al (1999) Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography. J Magn Reson Imaging 10:790-799
17. Taupitz M, Schnorr J, Wagner S et al (2001) Coronary magnetic resonance angiography: Experimental evaluation of the new rapid clearance blood pool contrast medium P792. Magn Reson Med 46:932-938
18. Lauffer RB, Parmelee DJ, Dunham SU et al (1998) MS-325: Albumin-targeted contrast agent for MR angiography. Radiology 207:529-538
19. Bluemke DA, Stillman AE, Bis KG et al (2001) Carotid MR angiography: phase II study of safety and efficacy for MS-325. Radiology 219:114-122
20. Lei T, Udupa JK, Saha PK et al (2002) 3D MRA visualization and artery-vein separation using blood-pool contrast agent MS-325. Acad Radiol 9(Suppl 1):S127-S133
21. Diamond GA, Forrester JS (1979) Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 300:1350-1358
22. Scheffler K, Hennig J (2001) T1 quantification with inversion recovery TrueFISP. Magn Reson Med 45:720-723
23. Look DC, Locker DR (1970) Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 41:250-251
24. Wendland MF, Saeed M, Lauerma K et al (1997) Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI. Magn Reson Med 37:448-456
25. Schlosser T, Hunold P, Herborn CU et al (2005) Myocardial infarct: depiction with contrast-enhanced MR imaging-comparison of gadopentetate and gadobenate. Radiology 236:1041-1046
26. Stuber M, Botnar RM, Danias PG et al (1999) Double-oblique free-breathing high resolution three-dimensional coronary magnetic resonance angiography. J Am Coll Cardiol 34:524-531
27. Nassenstein K, Waltering KU, Eggebrecht H, Schlosser T, Hunold P, Barkhausen J (2006) MR coronary angiography with MS-325, a blood pool contrast agent: Comparison of an inversion recovery steady-state free precession with an inversion recovery fast low angle shot sequence in volunteers. Rofo 178:508-514
28. Weber OM, Martin AJ, Higgins CB (2003) Whole-heart steady-state free precession coronary artery magnetic resonance angiography. Magn Reson Med 50:1223-1228
29. Bokacheva L, Huang AJ, Chen Q et al (2006) Single breath-hold T1 measurement using low flip angle TrueFISP. Magn Reson Med 55:1186-1190
30. Taylor AM, Panting JR, Keegan J et al (1999) Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography. J Magn Reson Imaging 9:220-227
31. Regenfus M, Ropers D, Achenbach S et al (2000) Noninvasive detection of coronary artery stenosis using contrast-enhanced three-dimensional breath-hold magnetic resonance coronary angiography. J Am Coll Cardiol 36:44-50
32. Zheng J, Bae KT, Woodard PK, Haacke EM, Li D (1999) Efficacy of slow infusion of gadolinium contrast agent in three-dimensional MR coronary artery imaging. J Magn Reson Imaging 10:800-805
33. Port M, Corot C, Raynal I et al (2001) Physicochemical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging. Invest Radiol 36:445-454
34. Misselwitz B, Schmitt-Willich H, Ebert W, Frenzel T, Weinmann HJ (2001) Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent. Magma 12:128-134